Literature DB >> 28730498

Informatics Approaches for Predicting, Understanding, and Testing Cancer Drug Combinations.

Jing Tang1,2.   

Abstract

Making cancer treatment more effective is one of the grand challenges in our health care system. However, many drugs have entered clinical trials but so far showed limited efficacy or induced rapid development of resistance. We urgently need multi-targeted drug combinations, which shall selectively inhibit the cancer cells and block the emergence of drug resistance. The book chapter focuses on mathematical and computational tools to facilitate the discovery of the most promising drug combinations to improve efficacy and prevent resistance. Data integration approaches that leverage drug-target interactions, cancer molecular features, and signaling pathways for predicting, understanding, and testing drug combinations are critically reviewed.

Entities:  

Keywords:  Data integration; Drug combinations; Informatics approaches; Mathematical modeling

Mesh:

Substances:

Year:  2017        PMID: 28730498      PMCID: PMC6322649          DOI: 10.1007/978-1-4939-7154-1_30

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  77 in total

1.  The problem of synergism and antagonism of combined drugs.

Authors:  S LOEWE
Journal:  Arzneimittelforschung       Date:  1953-06

2.  An overview of drug combination analysis with isobolograms.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2006-05-02       Impact factor: 4.030

3.  Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.

Authors:  Meir Glick; John W Davies; Jeremy L Jenkins
Journal:  J Chem Inf Model       Date:  2006 May-Jun       Impact factor: 4.956

4.  Systems biology and combination therapy in the quest for clinical efficacy.

Authors:  Jonathan B Fitzgerald; Birgit Schoeberl; Ulrik B Nielsen; Peter K Sorger
Journal:  Nat Chem Biol       Date:  2006-09       Impact factor: 15.040

Review 5.  Drugs, their targets and the nature and number of drug targets.

Authors:  Peter Imming; Christian Sinning; Achim Meyer
Journal:  Nat Rev Drug Discov       Date:  2006-10       Impact factor: 84.694

6.  Interaction index and different methods for determining drug interaction in combination therapy.

Authors:  J J Lee; M Kong; G D Ayers; R Lotan
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

7.  A quantitative analysis of kinase inhibitor selectivity.

Authors:  Mazen W Karaman; Sanna Herrgard; Daniel K Treiber; Paul Gallant; Corey E Atteridge; Brian T Campbell; Katrina W Chan; Pietro Ciceri; Mindy I Davis; Philip T Edeen; Raffaella Faraoni; Mark Floyd; Jeremy P Hunt; Daniel J Lockhart; Zdravko V Milanov; Michael J Morrison; Gabriel Pallares; Hitesh K Patel; Stephanie Pritchard; Lisa M Wodicka; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908

8.  A small molecule-kinase interaction map for clinical kinase inhibitors.

Authors:  Miles A Fabian; William H Biggs; Daniel K Treiber; Corey E Atteridge; Mihai D Azimioara; Michael G Benedetti; Todd A Carter; Pietro Ciceri; Philip T Edeen; Mark Floyd; Julia M Ford; Margaret Galvin; Jay L Gerlach; Robert M Grotzfeld; Sanna Herrgard; Darren E Insko; Michael A Insko; Andiliy G Lai; Jean-Michel Lélias; Shamal A Mehta; Zdravko V Milanov; Anne Marie Velasco; Lisa M Wodicka; Hitesh K Patel; Patrick P Zarrinkar; David J Lockhart
Journal:  Nat Biotechnol       Date:  2005-02-13       Impact factor: 54.908

9.  Systematic discovery of multicomponent therapeutics.

Authors:  Alexis A Borisy; Peter J Elliott; Nicole W Hurst; Margaret S Lee; Joseph Lehar; E Roydon Price; George Serbedzija; Grant R Zimmermann; Michael A Foley; Brent R Stockwell; Curtis T Keith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

10.  Chemical combination effects predict connectivity in biological systems.

Authors:  Joseph Lehár; Grant R Zimmermann; Andrew S Krueger; Raymond A Molnar; Jebediah T Ledell; Adrian M Heilbut; Glenn F Short; Leanne C Giusti; Garry P Nolan; Omar A Magid; Margaret S Lee; Alexis A Borisy; Brent R Stockwell; Curtis T Keith
Journal:  Mol Syst Biol       Date:  2007-02-27       Impact factor: 11.429

View more
  5 in total

1.  Comparative analysis of molecular fingerprints in prediction of drug combination effects.

Authors:  B Zagidullin; Z Wang; Y Guan; E Pitkänen; J Tang
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

2.  Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.

Authors:  Julian Scheper; Laura S Hildebrand; Eva-Maria Faulhaber; Lisa Deloch; Udo S Gaipl; Julia Symank; Rainer Fietkau; Luitpold V Distel; Markus Hecht; Tina Jost
Journal:  Strahlenther Onkol       Date:  2022-10-13       Impact factor: 4.033

Review 3.  Charting the Fragmented Landscape of Drug Synergy.

Authors:  Christian T Meyer; David J Wooten; Carlos F Lopez; Vito Quaranta
Journal:  Trends Pharmacol Sci       Date:  2020-02-26       Impact factor: 14.819

4.  DrugComb: an integrative cancer drug combination data portal.

Authors:  Bulat Zagidullin; Jehad Aldahdooh; Shuyu Zheng; Wenyu Wang; Yinyin Wang; Joseph Saad; Alina Malyutina; Mohieddin Jafari; Ziaurrehman Tanoli; Alberto Pessia; Jing Tang
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

5.  Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatids.

Authors:  Laura Fraccaroli; María Daniela Ruiz; Virginia Gabriela Perdomo; Agustina Nicole Clausi; Darío Emmanuel Balcazar; Luciana Larocca; Carolina Carrillo
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.